Cargando…
Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study
BACKGROUND: Magnetic resonance imaging (MRI) can be used to diagnose breast cancer. Diffusion weighted imaging (DWI) and the apparent diffusion coefficient (ADC) can reflect tumor microstructure in a non-invasive manner. The correct prediction of response of neoadjuvant chemotherapy (NAC) is crucial...
Autores principales: | Surov, Alexey, Pech, Maciej, Meyer, Hans-Jonas, Bitencourt, Almir G. V., Fujimoto, Hiroshi, Baxter, Gabrielle C., Santamaría, Gorane, Gilbert, Fiona J., Wienke, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733082/ https://www.ncbi.nlm.nih.gov/pubmed/36494872 http://dx.doi.org/10.1186/s40644-022-00501-2 |
Ejemplares similares
-
Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer
por: Surov, Alexey, et al.
Publicado: (2020) -
Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADC(mean)
por: Surov, Alexey, et al.
Publicado: (2017) -
Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADC(min)
por: Surov, Alexey, et al.
Publicado: (2018) -
Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis
por: Surov, Alexey, et al.
Publicado: (2017) -
Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions
por: Surov, Alexey, et al.
Publicado: (2019)